Yuanzhi Lu

Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway

Bhuvaneswari Ramaswamy, Yuanzhi Lu, Kun‐Yu Teng et al. · Cancer Research · 2012 · 189 citations · Full text

Hedgehog Signaling, Tamoxifen-resistant Breast Cancer, Tamoxifen Resistance +15

Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor

Shu‐Hao Hsu, Bo Yu, Xinmei Wang et al. · Nanomedicine Nanotechnology Biology and Medicine · 2013 · 175 citations · Full text

Nanoparticles, Nanomedicine, Engineering +11

Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis

Julia V. Burnier, N Wang, René P. Michel et al. · Oncogene · 2011 · 130 citations

Fibrosis, Medicine, Liver Physiology +8

Anti-microRNA-222 (Anti-miR-222) and -181B Suppress Growth of Tamoxifen-resistant Xenografts in Mouse by Targeting TIMP3 Protein and Modulating Mitogenic Signal

Yuanzhi Lu, Satavisha Roy, Gerard J. Nuovo et al. · Journal of Biological Chemistry · 2011 · 104 citations · Full text

Breast Oncology, Immunology, Cancer Biology +19

Ganetespib overcomes resistance to PARP inhibitors in breast cancer by targeting core proteins in the DNA repair machinery

Juhong Jiang, Yuanzhi Lu, Zhi Li et al. · Investigational New Drugs · 2017 · 31 citations

Drug Targeting, Medicine, Molecular Biology +7